Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Association between nutrient intake and serum high sensitivity C-reactive protein level in Korean adults: Using the data from 2015 Korea National Health and Nutrition Examination Survey

우리나라 성인의 영양소 섭취와 고감도 C-반응단백과의 연관성 연구 : 2015년 국민 건강영양조사 자료를 활용하여

  • Yoon, Ju-Gyeong (Department of Food and Nutrition, Chungnam National University) ;
  • Song, SuJin (Department of Food and Nutrition, Hannam University) ;
  • Cho, Jin Ah (Department of Food and Nutrition, Chungnam National University)
  • 윤주경 (충남대학교 식품영양학과) ;
  • 송수진 (한남대학교 식품영양학과) ;
  • 조진아 (충남대학교 식품영양학과)
  • Received : 2017.09.14
  • Accepted : 2017.10.31
  • Published : 2017.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: There have been limited studies investigating the relationship between high-sensitivity C-reactive protein (hsCRP), metabolic diseases, and dietary factors in Korean adults. Here, we examined the association between nutrient intake and serum hsCRP among Korean adults. Methods: Using data on 2,624 healthy Korean adults (1,537 women and 1,087 men) from the 2015 Korea National Health and Nutrition Examination Survey, demographic, anthropometric, biochemical, and dietary factors were analyzed once the subjects were grouped into either sex, age, or BMI. Nutrient intake was evaluated using the dietary data obtained by one-day 24-hour recall. Based on the guidelines of the US Centers for Disease Control and Prevention and the American Heart Association, hsCRP level was classified as HCRPG (High CRP Group, hsCRP > 1 mg/L) and LCRPG (Low CRP Group, hsCRP ${\leq}1mg/L$). Proc surveyreg procedure was performed to examine the associations between nutrient intake and hsCRP after adjustment for potential confounding variables. Results: The average hsCRP level of healthy Korean adults was $0.95{\pm}0.03mg/L$ ($0.97{\pm}0.04mg/L$ in men, $0.92{\pm}0.05mg/L$ in women). Obese subjects had significantly higher hsCRP than non-obese subjects in both sexes. The hsCRP level was positively associated with current smoking, physical inactivity, BMI, waist circumference, fasting blood glucose, triglycerides, total cholesterol, LDL-cholesterol, and blood pressure and inversely associated with HDL-cholesterol. LCRPG had significantly higher intake of dietary fiber compared to HCRPG in women. High hsCRP level was associated with more dietary cholesterol intake but less omega-3 fatty acid intake among subjects aged ${\geq}50y$. HCRPG of obese subjects had higher intakes of fat and saturated fatty acid than LCRPG. Conclusion: The hsCRP level is closely associated with several lifestyle variables and nutrient intake in healthy Korean adults. Individuals with high hsCRP level show low intakes of dietary fiber and omega-3 fatty acids but high intakes of dietary fat and cholesterol. Our findings suggest that a potential anti-inflammatory role for nutrients and lifestyle in the Korean adult population.

본 연구는 2015년 국민건강영양조사 자료를 활용하여 건강한 한국 성인 2,624명을 대상으로 염증 지표인 CRP의 분포를 파악하고 성별, 연령 (50세 기준), 비만여부 ($25kg/m^2$ 기준)로 구분하여 CRP 그룹 (1 mg/L 기준)에 따른 인구사회학적 지표, 생활습관 특성, 영양소 섭취와의 상관관계를 분석하였다. 건강한 성인에 해당하는 대상자들의 평균 CRP는 $0.95{\pm}0.03mg/L$으로, 국외에서 조사된 타 인종의 수치보다 낮은 수준에 해당한다. 남성, 50세 이상, 비만인 경우 평균 CRP가 유의적으로 높은 수치를 보였다. LCRPG과 HCRPG을 비교한 결과, 대상자의 분류에 따라 다른 특징을 보였고 대상자의 분류에 관계 없이 비만 여부, 허리둘레, 공복혈당의 경우 HCRPG이 더 높으며 HDL콜레스테롤의 경우 LCRPG에서 더 높은 수치를 나타냈다. 식사 변수 외에 흡연자와 비만에 해당하는 대상자는 HCRPG에 더 많고 신체활동을 실천하는 대상자는 LCRPG에 더 많이 분포하는 것으로 나타나 이러한 생활습관이 CRP 수치에 영향을 미치는 것으로 판단된다. 한편 교란인자의 보정 후 여성에서 HCRPG의 식이섬유 섭취량이 LCRPG보다 유의적으로 낮았으며, 50세 이상의 대상자에서 LCRPG 보다 HCRPG의 오메가3 지방산의 섭취량은 적었으며, 콜레스테롤 섭취량은 높았다. 또한 비만에 해당하는 대상자 중 HCRPG에서 지방의 에너지 기여율이 높고 지방과 포화 지방산의 섭취량이 높았다. 이러한 결과는 흡연, 신체활동과 같은 생활 습관뿐 아니라 식이섬유, 지방의 섭취량, 열량 에너지 섭취의 구성 또한 CRP 수준과 상관관계가 있음을 시사하며, 이는 식사와 만성염증과의 관련성을 제안할 수 있는 근거가 될 것으로 사료된다.

Keywords

References

  1. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386(10010): 2287-2323. https://doi.org/10.1016/S0140-6736(15)00128-2
  2. Korea Centers for Disease Control and Prevention. Chronic disease status and issues. Cheongju: Korea Centers for Disease Control and Prevention; 2015.
  3. Majno G, Joris I. Cells, tissues, and disease: principles of general pathology. 2nd edition. New York (NY): Oxford University Press; 2004.
  4. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454(7203): 428-435. https://doi.org/10.1038/nature07201
  5. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3(4): 276-285. https://doi.org/10.1038/nrc1046
  6. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91(4): 1351-1357. https://doi.org/10.1172/JCI116336
  7. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107(3): 499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45
  8. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106(5): 506-512. https://doi.org/10.1016/S0002-9343(99)00066-2
  9. Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther 2010; 4: 383-413.
  10. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002; 106(23): 2908-2912. https://doi.org/10.1161/01.CIR.0000041046.32962.86
  11. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 1997; 17(10): 2167-2176. https://doi.org/10.1161/01.ATV.17.10.2167
  12. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999; 353(9165): 1649-1652. https://doi.org/10.1016/S0140-6736(99)01046-6
  13. Muhammad IF, Borne Y, Hedblad B, Nilsson PM, Persson M, Engstrom G. Acute-phase proteins and incidence of diabetes: a population-based cohort study. Acta Diabetol 2016; 53(6): 981-989. https://doi.org/10.1007/s00592-016-0903-8
  14. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004; 93(10): 1238-1242. https://doi.org/10.1016/j.amjcard.2004.01.067
  15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336(14): 973-979. https://doi.org/10.1056/NEJM199704033361401
  16. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 2006; 84(6): 1489-1497. https://doi.org/10.1093/ajcn/84.6.1489
  17. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107(3): 443-447. https://doi.org/10.1161/01.CIR.0000045669.16499.EC
  18. Soltani S, Chitsazi MJ, Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: a systematic review and meta-analysis of randomized trials. Clin Nutr. Forthcoming 2017.
  19. Khayyatzadeh SS, Kazemi-Bajestani SM, Bagherniya M, Mehramiz M, Tayefi M, Ebrahimi M, Ferns GA, Safarian M, Ghayour-Mobarhan M. Serum high C reactive protein concentrations are related to the intake of dietary macronutrients and fiber: findings from a large representative Persian population sample. Clin Biochem 2017; 50(13-14): 750-755. https://doi.org/10.1016/j.clinbiochem.2017.03.016
  20. Ajani UA, Ford ES, Mokdad AH. Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey Data. J Nutr 2004; 134(5): 1181-1185. https://doi.org/10.1093/jn/134.5.1181
  21. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003; 92(11): 1335-1339. https://doi.org/10.1016/j.amjcard.2003.08.020
  22. Lee Y, Kang D, Lee SA. Effect of dietary patterns on serum C-reactive protein level. Nutr Metab Cardiovasc Dis 2014; 24(9): 1004-1011. https://doi.org/10.1016/j.numecd.2014.05.001
  23. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403): 157-163. https://doi.org/10.1016/S0140-6736(03)15268-3
  24. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ 3rd, Li W, Pagoto SL, Hafner AR, Ockene IS. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 2006; 83(4): 760-766. https://doi.org/10.1093/ajcn/83.4.760
  25. Ma Y, Hebert JR, Li W, Bertone-Johnson ER, Olendzki B, Pagoto SL, Tinker L, Rosal MC, Ockene IS, Ockene JK, Griffith JA, Liu S. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 2008; 24(10): 941-949. https://doi.org/10.1016/j.nut.2008.04.005
  26. Bode JG, Albrecht U, Haussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-${\kappa}B$-dependent signaling. Eur J Cell Biol 2012; 91(6-7): 496-505. https://doi.org/10.1016/j.ejcb.2011.09.008
  27. Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998; 44(6 Pt 1): 1358-1361.
  28. Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls. Clin Chem Lab Med 2001; 39(11): 1171-1176. https://doi.org/10.1515/CCLM.2001.185
  29. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 2002; 144(2): 233-238. https://doi.org/10.1067/mhj.2002.124054
  30. Yang EY, Nambi V, Tang Z, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Coresh J, Chambless L, Ballantyne CM. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2009; 54(25): 2388-2395. https://doi.org/10.1016/j.jacc.2009.10.006
  31. Hur M, Lee YK, Kang HJ, Lee KM. Distribution of high-sensitivity C-reactive protein in Korean healthy individuals. J Clin Pathol Qual Control 2001; 23(2): 259-63.
  32. Lear SA, Chen MM, Birmingham CL, Frohlich JJ. The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism 2003; 52(12): 1542-1546. https://doi.org/10.1016/j.metabol.2003.07.005
  33. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 2004; 24(8): 1509-1515. https://doi.org/10.1161/01.ATV.0000135845.95890.4e
  34. Rallidis LS, Kolomvotsou A, Lekakis J, Farajian P, Vamvakou G, Dagres N, Zolindaki M, Efstathiou S, Anastasiou-Nana M, Zampelas A. Short-term effects of Mediterranean-type diet intervention on soluble cellular adhesion molecules in subjects with abdominal obesity. Clin Nutr ESPEN 2017; 17: 38-43. https://doi.org/10.1016/j.clnesp.2016.11.002
  35. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69(1): 30-42. https://doi.org/10.1093/ajcn/69.1.30
  36. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients 2011; 3(10): 858-876. https://doi.org/10.3390/nu3100858
  37. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002; 252(4): 283-294. https://doi.org/10.1046/j.1365-2796.2002.01019.x
  38. Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, Bergeron J, Despres JP. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21(6): 961-967. https://doi.org/10.1161/01.ATV.21.6.961
  39. Navarro SL, Kantor ED, Song X, Milne GL, Lampe JW, Kratz M, White E. Factors associated with multiple biomarkers of systemic inflammation. Cancer Epidemiol Biomarkers Prev 2016; 25(3): 521-531. https://doi.org/10.1158/1055-9965.EPI-15-0956
  40. Jafari Salim S, Alizadeh S, Djalali M, Nematipour E, Hassan Javanbakht M. Effect of omega-3 polyunsaturated fatty acids supplementation on body composition and circulating levels of follistatin-like 1 in males with coronary artery disease: a randomized double-blind clinical trial. Am J Mens Health 2017; 11(6): 1758-1764. https://doi.org/10.1177/1557988317720581
  41. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001; 36(9): 1007-1024. https://doi.org/10.1007/s11745-001-0812-7
  42. Frohlich M, Sund M, Lowel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 2003; 24(14): 1365-1372. https://doi.org/10.1016/S0195-668X(03)00260-4
  43. Donges CE, Duffield R, Drinkwater EJ. Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sports Exerc 2010; 42(2): 304-313. https://doi.org/10.1249/MSS.0b013e3181b117ca
  44. Richardson MR, Churilla JR. Sleep duration and C-reactive protein in US adults. South Med J 2017; 110(4): 314-317. https://doi.org/10.14423/SMJ.0000000000000632
  45. Ironson G, Banerjee N, Fitch C, Krause N. Positive emotional well-being, health behaviors, and inflammation measured by C-reactive protein. Soc Sci Med. Forthcoming 2017.

Cited by

  1. Effects of Korean diet control nutrition education on cardiovascular disease risk factors in patients who underwent cardiovascular disease surgery vol.51, pp.3, 2018, https://doi.org/10.4163/jnh.2018.51.3.215